External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

SELLAS Life Sciences Group / Equity Bottom-Up

<ul><li>Author recommends going long on SELLAS Life Sciences (SLS) for significant upside potential</li><li>Current price of around $1.4 per share with a 1-year target price of $43 per share, projecting a 30x upside</li><li>SLS is expected to have a hard catalyst in the coming weeks, reducing science risk and offering more potential compared to previous investments in other companies</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Author recommends going long on SELLAS Life Sciences (SLS) for significant upside potentialCurrent price of around $1.4 per share with a 1-year target price of $43 per share, projecting a 30x upsideSLS is expected to have a hard catalyst in the coming weeks, reducing science risk and offering more potential compared to previous investments in other companiesThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Sellas Life Sciences Group I (SLS) - Thursday, Jun 13, 2024

United States

SELLAS Life Sciences Group, Inc. operates as a biopharmaceutical company. The Company develops late-stage oncology drugs and therapies for the treatment of cancer diseases. SELLAS Life Sciences Group serves patients worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SELLAS Life Sciences Group (SLS US)

Sellas Life Sciences Group I (SLS) - Thursday, Jun 13, 2024

SLS is expected to have a hard catalyst in the coming weeks, reducing science risk and offering more potential compared to previous investments in...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)